Pages that link to "Q1063862"
Jump to navigation
Jump to search
The following pages link to idarubicin (Q1063862):
Displayed 50 items.
- breast cancer (Q128581) (← links)
- acute myeloid leukemia (Q264118) (← links)
- acute promyelocytic leukemia (Q612108) (← links)
- chronic myeloid leukemia (Q729735) (← links)
- lymphoid leukemia (Q6708277) (← links)
- 7 3 (chemotherapy) (Q18040159) (← links)
- DNA topoisomerase II alpha (Q21108482) (← links)
- (7R,9R)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione (Q27165189) (← links)
- DNMT3A R882 (Q27908043) (← links)
- Idamycin (Q47521703) (← links)
- A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation (Q61862273) (← links)
- Combination Chemotherapy in Patients With Newly Diagnosed BPDCN (Q61907739) (← links)
- A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML) (Q61917580) (← links)
- SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia (Q61918327) (← links)
- Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) (Q61921767) (← links)
- A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia. (Q61934748) (← links)
- ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML) (Q61939162) (← links)
- Treatment Protocol of Children With Philadelphia Chromosome Negative High Risk Acute Lymphoblastic Leukemia (Q61970069) (← links)
- VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia (Q61979967) (← links)
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia (Q61980943) (← links)
- Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AML (Q62062297) (← links)
- Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents (Q62105164) (← links)
- Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia (Q62105613) (← links)
- Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission (Q62110032) (← links)
- Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia (Q62110196) (← links)
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia (Q62110351) (← links)
- Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma (Q62110378) (← links)
- Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma (Q62110545) (← links)
- Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia (Q62110562) (← links)
- Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (Q62110587) (← links)
- Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia (Q62110880) (← links)
- Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia (Q62110987) (← links)
- Cytarabine, Idarubicin, Liposome-encapsulated Daunorubicin-Cytarabine or Decitabine in Treating Older Patients With Acute Myeloid Leukemia (Q63013620) (← links)
- Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS (Q63319090) (← links)
- Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes (Q63336489) (← links)
- Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML) (Q63340104) (← links)
- Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL (Q63398830) (← links)
- Epacadostat, Idarubicin and Cytarabine (EIC) in AML (Q63402466) (← links)
- Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015) (Q63405255) (← links)
- A Global Study of the Efficacy and Safety of Midostaurin Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML) (Q63571887) (← links)
- Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd Salvage (Q63572645) (← links)
- Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia (Q63575178) (← links)
- Study of the BCL-2 Inhibitor Venetoclax in Combination With Standard Intensive Acute Myeloid Leukemia (AML) Induction/Consolidation Therapy With FLAG-IDA in Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia (AML) (Q63575894) (← links)
- A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma (Q63578207) (← links)
- Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation (Q63578421) (← links)
- Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (Q63590931) (← links)
- HDM201 Added to CT in R/R or Newly Diagnosed AML (Q63592217) (← links)
- Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion (Q63596878) (← links)
- A Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML (Q63599325) (← links)
- Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers (Q63599929) (← links)